Immunovant (IMVT) PT Raised to $57 at Stifel
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Price: $44.35 --0%
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 17
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 17
Join SI Premium – FREE
Stifel analyst Alex Thompson raised the price target on Immunovant (NASDAQ: IMVT) to $57.00 (from $49.00) while maintaining a Buy rating.
You May Also Be Interested In
- Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
- Genesis Minerals Ltd (GMD:AU) PT Raised to AUD9.80 at UBS
- Universal Store Holdings (UNI:AU) PT Raised to AUD9.25 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
